Total Funding
16
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 16 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
438004
Ikaria is a critical care firm that develop innovative therapeutics and interventions to meet the significant needs of critically.
Acquired by 

Mallinckrodt
- Azin Parhizgar: Scientific Advisory Board memberPast Role: Claret Medical, President & CEO
About the Company
Ikaria develop and deliver innovative therapeutics and interventions to meet the significant needs of critically ill patients. It is our aim to be an indispensable partner to clinicians, providing help and critically caring just when patients need it the most.

